KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Times Interest Earned (2018 - 2025)

Castle Biosciences' Times Interest Earned history spans 7 years, with the latest figure at -$159.46 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 678.77% year-over-year to -$159.46; the TTM value through Dec 2025 reached -$497.79, down 3412.86%, while the annual FY2025 figure was -$497.79, 3412.86% down from the prior year.
  • Times Interest Earned for Q4 2025 was -$159.46 at Castle Biosciences, up from -$283.5 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $27.55 in Q4 2024 and bottomed at -$15171.0 in Q4 2021.
  • The 5-year median for Times Interest Earned is -$1642.8 (2025), against an average of -$3463.7.
  • The largest annual shift saw Times Interest Earned tumbled 197543.3% in 2021 before it surged 100.97% in 2024.
  • A 5-year view of Times Interest Earned shows it stood at -$15171.0 in 2021, then skyrocketed by 62.38% to -$5708.0 in 2022, then surged by 50.44% to -$2829.0 in 2023, then soared by 100.97% to $27.55 in 2024, then tumbled by 678.77% to -$159.46 in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Times Interest Earned are -$159.46 (Q4 2025), -$283.5 (Q3 2025), and -$202.43 (Q2 2025).